Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.67
Delayed Data
As of Feb 26
 +0.06 / +3.73%
Today’s Change
0.97
Today|||52-Week Range
2.12
-11.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues535.0K751.8K1.1M2.3M
 
 
 
 
 
Cost of Goods Sold67.9K82.0K146.4K682.5K
 
 
 
 
 
Depreciation And Amortization84.0K111.3K124.1K125.3K
 
 
 
 
 
 
Operating ExpensesGross Income383.0K558.6K804.2K1.4M
 
 
 
 
 
General Expenses13.4M9.1M8.6M6.7M
 
 
 
 
 
Research And Development9.4M5.2M5.1M4.2M
 
 
 
 
 
Total Operating Expenses13.6M9.3M8.9M7.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.1M-8.6M-7.8M-5.3M
 
 
 
 
 
Extraordinary Credit265.4K392.5K0.000.00
 
 
 
Extraordinary Charge---2.6M-1.5M-472.7K
 
 
 
 
Pre-Tax Equity Earnings0.000.00---262.2K
 
 
Interest Expense On Debt974.2K943.8K914.1K920.9K
 
 
 
 
 
Other Expenses123.00-6.8K-5.3K53.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.8M-11.7M-10.2M-6.9M
 
 
 
 
 
Net Income-13.8M-11.7M-10.2M-6.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS133.9M144.8M150.0M150.2M
 
 
 
 
 
Shares To Calculate EPS Diluted133.9M144.8M150.0M150.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.08-$0.07-$0.05
 
 
 
 
 
EPS Diluted-$0.10-$0.08-$0.07-$0.05
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account